IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $263,666 | -66.9% | 32,876 | -38.8% | 0.04% | -63.4% |
| Q1 2024 | $795,953 | +230.7% | 53,708 | +81.4% | 0.10% | +114.9% |
| Q4 2023 | $240,664 | +732.2% | 29,602 | +365.7% | 0.05% | +487.5% |
| Q3 2023 | $28,920 | +39.6% | 6,356 | +116.0% | 0.01% | +33.3% |
| Q2 2023 | $20,712 | +11.6% | 2,942 | -3.2% | 0.01% | 0.0% |
| Q1 2023 | $18,562 | +81.2% | 3,038 | +89.5% | 0.01% | +50.0% |
| Q4 2022 | $10,243 | -26.8% | 1,603 | +8.5% | 0.00% | -33.3% |
| Q3 2022 | $14,000 | – | 1,478 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
| MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
| Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
| CM Management, LLC | 200,000 | $910,000 | 0.97% |
| Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
| Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
| Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
| Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
| 683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |